Terms: = Breast cancer AND BCL11A, BCL11A-L, 53335, ENSG00000119866, FLJ34997, CTIP1, BCL11A-S, BCL11A-XL, KIAA1809, Q9H165, EVI9, FLJ10173
18 results:
1. Exploration of Key Immune-Related Transcriptomes Associated with Doxorubicin-Induced Cardiotoxicity in Patients with breast cancer.
Xiong D; Yang J; Li D; Wang J
Cardiovasc Toxicol; 2023 Oct; 23(9-10):329-348. PubMed ID: 37684436
[TBL] [Abstract] [Full Text] [Related]
2. A feedback loop between lncRNA MALAT1 and DNMT1 promotes triple-negative breast cancer stemness and tumorigenesis.
Hu Y; He Y; Luo N; Li X; Guo L; Zhang K
Cancer Biol Ther; 2023 Dec; 24(1):2235768. PubMed ID: 37548553
[TBL] [Abstract] [Full Text] [Related]
3. BaySyn: Bayesian Evidence Synthesis for Multi-system Multiomic Integration.
Bhattacharyya R; Henderson N; Baladandayuthapani V
Pac Symp Biocomput; 2023; 28():275-286. PubMed ID: 36540984
[TBL] [Abstract] [Full Text] [Related]
4. Deciphering clinical significance of bcl11a isoforms and protein expression roles in triple-negative breast cancer subtype.
Angius A; Pira G; Cossu-Rocca P; Sotgiu G; Saderi L; Muroni MR; Virdis P; Piras D; Vincenzo R; Carru C; Coradduzza D; Uras MG; Cottu P; Fancellu A; Orrù S; Uva P; De Miglio MR
J Cancer Res Clin Oncol; 2023 Jul; 149(7):3951-3963. PubMed ID: 36030436
[TBL] [Abstract] [Full Text] [Related]
5. Integrated bioinformatics and statistical approaches to explore molecular biomarkers for breast cancer diagnosis, prognosis and therapies.
Alam MS; Sultana A; Reza MS; Amanullah M; Kabir SR; Mollah MNH
PLoS One; 2022; 17(5):e0268967. PubMed ID: 35617355
[TBL] [Abstract] [Full Text] [Related]
6. Network Analysis Identifies Regulators of Basal-Like breast cancer Reprogramming and Endocrine Therapy Vulnerability.
Choi SR; Hwang CY; Lee J; Cho KH
Cancer Res; 2022 Jan; 82(2):320-333. PubMed ID: 34845001
[TBL] [Abstract] [Full Text] [Related]
7. The transcriptional repressor bcl11a promotes breast cancer metastasis.
Seachrist DD; Hannigan MM; Ingles NN; Webb BM; Weber-Bonk KL; Yu P; Bebek G; Singh S; Sizemore ST; Varadan V; Licatalosi DD; Keri RA
J Biol Chem; 2020 Aug; 295(33):11707-11719. PubMed ID: 32576660
[TBL] [Abstract] [Full Text] [Related]
8. miR‑574‑5p attenuates proliferation, migration and EMT in triple‑negative breast cancer cells by targeting bcl11a and SOX2 to inhibit the SKIL/TAZ/CTGF axis.
Zhang KJ; Hu Y; Luo N; Li X; Chen FY; Yuan JQ; Guo L
Int J Oncol; 2020 May; 56(5):1240-1251. PubMed ID: 32319565
[TBL] [Abstract] [Full Text] [Related]
9. Next-generation sequencing identifies recurrent copy number variations in invasive breast carcinomas from Ghana.
Anwar T; Rufail ML; Djomehri SI; Gonzalez ME; Lazo de la Vega L; Tomlins SA; Newman LA; Kleer CG
Mod Pathol; 2020 Aug; 33(8):1537-1545. PubMed ID: 32152520
[TBL] [Abstract] [Full Text] [Related]
10. Exploring specific prognostic biomarkers in triple-negative breast cancer.
Bao C; Lu Y; Chen J; Chen D; Lou W; Ding B; Xu L; Fan W
Cell Death Dis; 2019 Oct; 10(11):807. PubMed ID: 31649243
[TBL] [Abstract] [Full Text] [Related]
11. ST8SIA1 Regulates Tumor Growth and Metastasis in TNBC by Activating the FAK-AKT-mTOR Signaling Pathway.
Nguyen K; Yan Y; Yuan B; Dasgupta A; Sun J; Mu H; Do KA; Ueno NT; Andreeff M; Battula VL
Mol Cancer Ther; 2018 Dec; 17(12):2689-2701. PubMed ID: 30237308
[TBL] [Abstract] [Full Text] [Related]
12. circEPSTI1 as a Prognostic Marker and Mediator of Triple-Negative breast cancer Progression.
Chen B; Wei W; Huang X; Xie X; Kong Y; Dai D; Yang L; Wang J; Tang H; Xie X
Theranostics; 2018; 8(14):4003-4015. PubMed ID: 30083277
[TBL] [Abstract] [Full Text] [Related]
13. MiR-137 Suppresses Triple-Negative breast cancer Stemness and Tumorigenesis by Perturbing bcl11a-DNMT1 Interaction.
Chen F; Luo N; Hu Y; Li X; Zhang K
Cell Physiol Biochem; 2018; 47(5):2147-2158. PubMed ID: 29975921
[TBL] [Abstract] [Full Text] [Related]
14. Probing the interaction between the histone methyltransferase/deacetylase subunit RBBP4/7 and the transcription factor bcl11a in epigenetic complexes.
Moody RR; Lo MC; Meagher JL; Lin CC; Stevers NO; Tinsley SL; Jung I; Matvekas A; Stuckey JA; Sun D
J Biol Chem; 2018 Feb; 293(6):2125-2136. PubMed ID: 29263092
[TBL] [Abstract] [Full Text] [Related]
15. A New Gene Expression Signature for Triple Negative breast cancer Using Frozen Fresh Tissue before Neoadjuvant Chemotherapy.
Santuario-Facio SK; Cardona-Huerta S; Perez-Paramo YX; Trevino V; Hernandez-Cabrera F; Rojas-Martinez A; Uscanga-Perales G; Martinez-Rodriguez JL; Martinez-Jacobo L; Padilla-Rivas G; Muñoz-Maldonado G; Gonzalez-Guerrero JF; Valero-Gomez J; Vazquez-Guerrero AL; Martinez-Rodriguez HG; Barboza-Quintana A; Barboza-Quintana O; Garza-Guajardo R; Ortiz-Lopez R
Mol Med; 2017 Jun; 23():101-111. PubMed ID: 28474731
[TBL] [Abstract] [Full Text] [Related]
16. [Knock-down of bcl11a expression in breast cancer cells promotes MDA-MB-231 cell apoptosis].
Li H; Gui C; Yan L
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Nov; 32(11):1532-1535. PubMed ID: 27774950
[TBL] [Abstract] [Full Text] [Related]
17. bcl11a is a triple-negative breast cancer gene with critical functions in stem and progenitor cells.
Khaled WT; Choon Lee S; Stingl J; Chen X; Raza Ali H; Rueda OM; Hadi F; Wang J; Yu Y; Chin SF; Stratton M; Futreal A; Jenkins NA; Aparicio S; Copeland NG; Watson CJ; Caldas C; Liu P
Nat Commun; 2015 Jan; 6():5987. PubMed ID: 25574598
[TBL] [Abstract] [Full Text] [Related]
18. Reverse-phase protein array for prediction of patients at low risk of developing bone metastasis from breast cancer.
Hayashi N; Manyam GC; Gonzalez-Angulo AM; Niikura N; Yamauchi H; Nakamura S; Hortobágyi GN; Baggerly KA; Ueno NT
Oncologist; 2014 Sep; 19(9):909-14. PubMed ID: 25117064
[TBL] [Abstract] [Full Text] [Related]
